Alfa glucosidase inhibitor: Voglibose can prevent progression of impaired glucose tolerance stage to type II diabetes mellitus

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 5, Issue 6, 2014, Pages 654-661

  Naik, Manas Ranjan ^a   Agrawal, Divya ^a   Kumar, Sanjay ^a   Mishra, Sudhanshu Sekhar ^a  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

Acarbose; Diabetes; FBS; Glycosylated Hb; Metformin; PPBS; Voglibose

Indexed keywords

ACARBOSE; ALOGLIPTIN; GASTROINTESTINAL POLYPEPTIDE; GLUCAGON INHIBITORY PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PIOGLITAZONE; SULFONYLUREA; UNCLASSIFIED DRUG; VOGLIBOSE;

ABDOMINAL DISCOMFORT; ARTICLE; BLOATING; BODY WEIGHT; CARDIOVASCULAR EFFECT; CHOLESTASIS; COMPARATIVE STUDY; DIABETES CONTROL; DIET THERAPY; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEPATITIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; JAUNDICE; LIPID ANALYSIS; LONG TERM CARE; MOLECULAR WEIGHT; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN SECRETION; VOMITING;

MUS;

EID: 84911057707     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Sacks DB. Clin Chem 1997;43:2230-2236.
2. Naik MR, Bhattacharya A, AgrawalD, Swain TR, KumarS, Mishra SS. Res J Pharm Biol Chem Sci 2014; 5(4):1071-1080
3. Bischoff H. Clin Invest Med 1995; 18:303-11.
4. New Engl J Med 1993; 329:977-86.
5. Unger RH. Diabetes 1995; 44:863-870.
6. Lebovilz HE. 1992; 44:21-28.
7. Rabasa - Lhoret R. Chaisson J. Drug Aging 1998; 13:131-43.
8. Balfour JA, McTavish D. Drugs 1993; 46:1025.
9. Rosen Stock J. Manager J, Kro IT. Diabetes 1998; 47:1357.
10. Halimi S, Le Berre MA, GrangeVDiabetes Res Clin Pract 2000; 50:49-56.
11. Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC. Diabetes Care 21:1154-8.
12. Ajay S. Dhabi, Nikita R. Bhatt, Mohit J. Shah. JCDR 2013; 7:3023-3027.
13. Chenx, Zheng Y, Shen Y. Curr Med Chem 2006.
14. Johnston PS, Coniff RF, Hoogwerf BJ, Santiago JV. Diabetes Care 1994; 17:20-29.
15. Coniff RF, Shapiro JA, Robbins D, Klrenfield R. Diabetes Care 1995; 18:817-824.
16. Leahy JL. Diabetes Rev 1996; 4:298-319.
17. Sako Y, Grill VE. Diabetes 1990; 39:1580-1583.
18. Kazunari Matsumoto, Moyumi Yano, Seibei Miyake. Emerging Treatments and Technologies 1997.
19. Chaisson JL, Josse RG, Leiter LA. Diabetes Care 1996; 19:1190-1193.
20. Shinozaki K, Suzuki M, Lkebuchi M, Hirose J. Metabol 1996; 45:731-737.
21. Kahn SE, Prigeon RL, McCulloh. Diabetes 1993; 42:1663-1672.
22. Rossetti L, Giaccari A, Defronzo RA. Diabetes Care 1990: 13:610-630.
23. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamotok Kakuk. The Lancet 2009; 373:1607-1614.
24. Rosenthal JH, Meuserger. Clin Drug Invest 2002; 22:695-701.
25. Bayraktar M et al. Diabetes Care 1996; 19:252.
26. Sheen AJ. Metabol 1998; 24:311-320.
27. Buse JB, Tan MH, Prince MJ. Diabetes Obes Metabol 2004; 6:133-156.
28. Kazuya Shinojaki et al. Metabol 1996; 6:731-737.
29. Negishi M, Shimomura K, Porks P, Shimomura Y, Mori M. Endocr J 2011; 58 (6):425-32.
30. Abe M, Kikachi F, Kaizu K, Matsumoto K. Clin Nephrol 2007; 68:287-94.
31. Kobatake T, Matsuzawa y, Tokunga K. Metabolic improvements associated with a reduction of abdommal visceral fat caused by a new alfoglucosidase inhibitor AO-128, in Zucker Fatty rats 1989.
32. YostimitshuYamaski et al. Diabetes Res Clin Pract 2005; 67(3).
33. Takashima S, ZhaO H, Asano. Control of plasma glucose with glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. 2006.
34. www.wikigenes.com/voglibose.
35. Thara K. Acta Poediatric 1998; 87:545-98.
36. Matsumoto K. Metabol 2002; 51:1548-52.
37. Seino Y, Fujita T, Hiroi S, Hirayama M, Kaku K. Curr Med Res Opin 2011; 27 (3):21-99.
38. Hiyoshi T, Shiozaki M, InourM. Ther Res 2013; 34 (3):379-90.
39. Goke B. Digestion 1995;56 (6):493-501.
40. Takahisa H. Diab Res Clin Pract 2000; 54:9-15
41. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A. Nippon Rinsha Japanese Journal of Clinical Medicine 2009; 67 (9):1821-25.
42. Vichayanrat A, Polybutr S, Tunkalit M. Diabetes Res Clin Pr 2002; 55:99-103.
43. Kageyama S, Nakamichi No, Sekmo H. Clin Ther 1997; 19:720-9.
44. Koh N, Sakamoto S, Chino F. Tohoku J Exp Med 2008; 216 (3):249-57.
45. www.biocon.com/voglibosedispersabletablets.